Remove 2018 Remove Blogging Remove Pricing
article thumbnail

Arcutis Bio Raises $159M in Upsized IPO to Test Skin Disease Drugs

Xconomy

million more shares than anticipated and pricing at the high end of its planned range. The stock price closed at $21.80, up 28 percent. In July 2018, the company licensed. Arcutis Biotherapeutics raised about $159 million from its IPO, offering 1.6 The Westlake Village, CA-based biotech sold about 9.4

article thumbnail

Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials

Xconomy

Five biotechs priced their IPOs and at least one more is coming. According to IPO research firm Renaissance Capital , 47 IPOs have priced so far this year across all sectors, down 27 percent compared to the same period in 2018. Just as last year, healthcare IPOs lead the way.

Pricing 110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

SPECIAL REPORT: 2019 Blockchain Outlook — Reality Check

Xconomy

After a breakout year in 2017, the blockchain sector suffered a series of blows in 2018, from crashing cryptocurrency prices to increased regulatory scrutiny of crypto ventures and deepening skepticism about whether the technology was actually useful.

Report 98
article thumbnail

Xconomy Roadmap 2018: Top 15 Innovation Areas to Watch

Xconomy

View the Slideshow With the first quarter in the books, it’s time to step back and lay out Xconomy’s editorial map for the rest of the year.

News 86
article thumbnail

ResMed To Add To Software Offerings With $750M MatrixCare Acquisition

Xconomy

The purchase price is 25 times MatrixCare’s pro forma 2018 earnings of about $30 million (without taking into account interest, taxes, depreciation or amortization) on anticipated net revenue of about $122 million. San Diego’s ResMed (NYSE: ticker[[RMD]]) announced its intention to buy the privately held tech company on Monday.

article thumbnail

Genmab, Mirum Pharma & Fulcrum Raise $653M in Wall Street Debuts

Xconomy

Here’s a recap of the biotech companies that priced IPOs Wednesday evening. The Denmark-based biopharmaceutical company is a large, international organization whose commercialized products contributed to its $455 million-plus in 2018 revenue.

article thumbnail

8 Tips For Quantifying Traction In Your New Venture

Startup Professionals Musings

According to most investors I know, traction is some clear evidence that the “dogs are eating the dog food” – usually meaning that you have at least one customer paying full price for your solution. These would include cost of customer acquisition, cost of leads, sales channel, cost of goods, and pricing strategy.

Tips 79